National Institute Of Allergy And Infectious Diseases
-
Vanderbilt, NIH and the Institut National de Recherche Biomédicale team up to tackle monkeypox
In this international research cooperation, Vanderbilt is leading the development of AI to automatically localize and count monkeypox lesions, the main measure of disease severity, and spearheading a guideline to classify monkeypox lesions. Read MoreSep 15, 2022
-
Research Snapshot: Discovery of mosquito survival tactics leaves room for new disease vector control tactics
Mosquito-borne diseases like malaria represent an ongoing global health crisis of (literally) biblical proportions. LJ Zwiebel has identified the biological factors that help female mosquitos mate, suck blood and sense environmental threats. Est. reading time: 1.5 mins. Read MoreJun 1, 2022
-
Vanderbilt researchers develop new evolutionary approach for identifying proteins that functionally interact
Graduate student measures the coevolution of genes in genomes; method may fundamentally change how we identify genes with similar functions. Read MoreMay 4, 2022
-
SARS-CoV-2 protein blocks an essential step in host gene expression, new discovery finds
Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read MoreFeb 17, 2021
-
Remdesivir helps reduce COVID-19 recovery time: study
The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. Read MoreJun 4, 2020
-
Inflammation relief: what’s the delay?
New research offers hope for patients needing the anti-inflammatory benefits of glucocorticoids without the adverse side effects associated with them. Read MoreJun 28, 2011